Compare TOON & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOON | IXHL |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9M | 37.0M |
| IPO Year | 2014 | 2024 |
| Metric | TOON | IXHL |
|---|---|---|
| Price | $0.64 | $3.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 223.3K | 81.1K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.26 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $39,353,000.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.14 | ★ N/A |
| Revenue Growth | ★ 20.75 | N/A |
| 52 Week Low | $0.50 | $0.16 |
| 52 Week High | $1.29 | $6.39 |
| Indicator | TOON | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | 67.06 |
| Support Level | $0.58 | $2.79 |
| Resistance Level | $0.76 | $4.03 |
| Average True Range (ATR) | 0.04 | 0.16 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 59.94 | 71.76 |
Kartoon Studios Inc is a media company developing, producing, marketing, and licensing branded animated entertainment properties and consumer products for media and retail distribution. Its portfolio features programming for toddlers to tweens, including the preschool properties Rainbow Rangers for Nick Jr. and Llama Llama for Netflix, Stan Lee's Superhero Kindergarten, Shaq's Garage, toddler brand Baby Genius, STEM-based series Thomas Edison's Secret Lab, Warren Buffett's Secret Millionaires Club, and the new preschool show, Stan Lee's Superhero Kindergarten. Its channel is available on television and mobile devices through distribution platforms, including Comcast, Cox, DISH, Sling TV, Apple TV, Roku, Android TV, Tubi, Xumo, and Amazon Fire.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.